Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > FDA Needs to Systematically Collect Vital Nanotech Data, Attorney Says

Abstract:
Hundreds of nanotech products, including foods, medicines and medical devices, now have reached the market, and their number will grow exponentially in the years ahead. But the main regulatory body, the Food and Drug Administration, is not yet systematically collecting basic nanomaterial information, says John C. Monica, Jr., a partner at the law firm of Porter Wright Morris & Arthur LLP, in Washington, D.C, and head of the firm's nanotechnology practice group.

FDA Needs to Systematically Collect Vital Nanotech Data, Attorney Says

Washington, DC | Posted on February 20th, 2008

In an Insighter article, posted on the Food and Drug Law Institute's website, http://www.fdli.org/, Monica notes that FDA maintains that current laws and rules are probably adequate for most nanotechnology products regulated by the agency. But such issues of authority are overshadowed by an even more basic question of agency oversight, according to Monica, who writes: "To illustrate, try this: Place a general telephone call or email inquiry to FDA and ask whether the agency keeps a list of FDA-approved products employing nanoscale materials. Then dig deeper and call each of the six FDA centers (CDER, CFSAN, CBER, CVM, CDRH, and NCTR) and ask the same question. Unfortunately, no such list exists. In fact, FDA freely admits that it does not currently track this information."

Thus, Monica asserts, the larger question becomes whether the agency can appropriately react if a future problem is discovered related to the "nanoness" of one of its regulated products. Until the science is in, products using nanotechnology should be tracked and specifically monitored, concludes Monica. "FDA must be prepared to investigate whether other approved products might be susceptible to similar problems. The public will demand nothing less," says Monica, adding: "Right now, unfortunately, FDA does not even know which products contain nanoscale materials and has no definitive way of quickly making this determination."

The Food and Drug Law Institute's 1st Annual Conference on Nanotechnology Law, Regulation and Policy, co-sponsored by Woodrow Wilson International Center for Scholars Project on Emerging Nanotechnologies, in partnership with Burdock Group and Arizona State University, Feb. 28-29 in Washington, D.C., will focus on this and other important legal and regulatory issues concerning nanotechnology.

For more information on the conference, visit www.fdli.org/conf or contact Michael Levin-Epstein, Editor-in-Chief, (202) 222-0897 or

The full text of the Insighter piece is posted at www.fdli.org

####

About Food and Drug Law Institute
Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field.

For more information, please click here

Contacts:
Michael Levin-Epstein
Editor-in-Chief
(202) 222-0897

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Govt.-Legislation/Regulation/Funding/Policy

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

Rutgers-Led Innovation Could Spur Faster, Cheaper, Nano-Based Manufacturing: Scalable and cost-effective manufacturing of thin film devices February 14th, 2018

Understanding brain functions using upconversion nanoparticles: Researchers can now send light deep into the brain to study neural activities February 14th, 2018

Announcements

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Safety-Nanoparticles/Risk management

How harmful are nano-copper and anti-fungal combinations in the waterways? October 27th, 2017

Do titanium dioxide particles from orthopedic implants disrupt bone repair? September 16th, 2017

Tests show no nanotubes released during utilisation of nanoaugmented materials June 9th, 2017

NanoMONITOR shares its latest developments concerning the NanoMONITOR Software and the Monitoring stations April 21st, 2017

Events/Classes

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Leti’s Chief Scientist Presents Optimistic Vision for Neuromorphic Hardware and Ultra-Low-Power Microdevices for Edge Computing at ISSCC: Leti’s Chief Scientist Presents Optimistic Vision for Neuromorphic Hardware and Ultra-Low-Power Microdevices That Are Based on Novel Emerging February 13th, 2018

Leti Chief Scientist Barbara De Salvo Will Help Kick Off ISSCC 2018 with Opening-Day Keynote: In Addition, Leti Scientists Will Present and Demo New Technology for Piezoelectric Energy Harvesting February 8th, 2018

Leti Presents Optical-Equipment Curving Technology that Improves Performance, Cuts Costs: ‘Disruptive Approach’ for Imaging Applications Presented in Paper At Photonics West and Demonstrated in Leti’s Booth February 2nd, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project